Read Research Alzheimer's More http://fuckalzheimers.com/2019/09/26/perspective-clinical-relevance-of-the-dichotomous-classification-of-alzheimers-disease-biomarkers-should-there-be-a-gray-zone/' title='Share this by email.' class='social email'>           

Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a “gray zone”?

The 2018 National Institute on Aging and the Alzheimer’s Association (NIA-AA) research framework recently redefined Alzheimer’s disease (AD) as a biological construct, based on in vivo biomarkers reflecting key neuropathologic features. Combinations of normal/abnormal levels of three biomarker categories, based on single thresholds, form the AD signature profile that defines the Read & Research Alzheimer’s More

Leave a Reply